SCM
CERE

Suvretta Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Suvretta Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150,000
Closed -$1.57M – 129
2020
Q3 		$1.57M Buy
+150,000
New +$1.57M 0.03% 80